Assembly Biosciences Inc (ASMB)
13.15
+0.34
(+2.65%)
USD |
NASDAQ |
May 03, 16:00
13.14
-0.01
(-0.08%)
After-Hours: 20:00
Assembly Biosciences Revenue (TTM)
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2020 | 79.10M |
| September 30, 2020 | 82.83M |
| June 30, 2020 | 52.45M |
| March 31, 2020 | 16.16M |
| December 31, 2019 | 15.96M |
| September 30, 2019 | 14.93M |
| June 30, 2019 | 14.99M |
| Date | Value |
|---|---|
| March 31, 2019 | 15.12M |
| December 31, 2018 | 14.80M |
| September 30, 2018 | 14.38M |
| June 30, 2018 | 12.76M |
| March 31, 2018 | 11.90M |
| December 31, 2017 | 9.019M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
14.93M
Minimum
Sep 2019
82.83M
Maximum
Sep 2020
39.49M
Average
16.16M
Median
Mar 2020
Revenue (TTM) Benchmarks
| NovaBay Pharmaceuticals Inc | 14.73M |
| Palatin Technologies Inc | 7.098M |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |